AIDS therapy /
Saved in:
| மறà¯à®± எழà¯à®¤à¯à®¤à®¾à®³à®°à¯à®•ளà¯: | , , |
|---|---|
| வடிவமà¯: | பà¯à®¤à¯à®¤à®•ம௠|
| மொழி: | English |
| வெளியீடபà¯à®ªà®Ÿà¯à®Ÿà®¤à¯: |
New York :
Churchill Livingstone,
c1999.
|
| பகà¯à®¤à®¿à®•ளà¯: | |
| கà¯à®±à®¿à®¯à¯€à®Ÿà¯à®•ளà¯: |
கà¯à®±à®¿à®šà¯à®šà¯Šà®²à¯ இணை
கà¯à®±à®¿à®¯à¯€à®Ÿà¯à®•ள௠இலà¯à®²à¯ˆ, இநà¯à®¤ கà¯à®±à®¿à®šà¯à®šà¯Šà®²à¯à®²à¯ˆ à®®à¯à®¤à®²à®¿à®²à¯ பதிவ௠செயà¯à®¯à¯à®™à¯à®•ளà¯!
|
| LEADER | 01514pam a2200349 a 4500 | ||
|---|---|---|---|
| 001 | 008058894-8 | ||
| 005 | 20020606104010.5 | ||
| 008 | 980722s1999 nyuaf b 001 0 eng c | ||
| 010 | |a 98034773 | ||
| 020 | |a 0443075921 | ||
| 035 | 0 | |a ocm39625387 | |
| 040 | |a DNLM/DLC |c DLC |d DLC | ||
| 050 | 0 | 0 | |a RC607.A26 |b A3675 1999 |
| 060 | 0 | 0 | |a WC 503.2 |b A2885 1999 |
| 082 | 0 | 0 | |a 616.97/9206 |2 21 |
| 245 | 0 | 0 | |a AIDS therapy / |c [edited by] Raphael Dolin, Henry Masur, Michael S. Saag. |
| 260 | |a New York : |b Churchill Livingstone, |c c1999. | ||
| 300 | |a xv, 864 p. [2] leaves of plates : |b ill. ; |c 29 cm. | ||
| 504 | |a Includes bibliographical references and index. | ||
| 505 | 0 | |a Diagnosis of HIV infection-- Antiretroviral therapy-- Immune-based therapies-- Other therapies, including alternative therapies-- Strategies for managing antiretroviral therapies-- Diagnosis, therapy, and prevention of opportunistic processes-- Approach to specific syndromes-- Drug administration and interactions. | |
| 650 | 0 | |a AIDS (Disease) |x Treatment. | |
| 650 | 0 | |a AIDS (Disease) |x Chemotherapy. | |
| 650 | 0 | |a Antiviral agents. | |
| 650 | 0 | |a Opportunistic infections |x Treatment. | |
| 650 | 0 | |a AIDS (Disease) |x Complications |x Treatment. | |
| 650 | 1 | 2 | |a Acquired Immunodeficiency Syndrome |x therapy. |
| 700 | 1 | |a Dolin, Raphael. | |
| 700 | 1 | |a Masur, Henry. | |
| 700 | 1 | |a Saag, Michael S. | |
| 776 | 0 | 8 | |i Online version: |t AIDS therapy. |d Philadelphia : Churchill Livingstone, ©1999 |w (OCoLC)607139283 |
| 988 | |a 20020608 | ||
| 906 | |0 OCLC | ||


